IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype

Takahiro Masuda1, Makoto Tsuda1, Ryohei Yoshinaga1

  • 1Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan.

Cell Reports
|July 27, 2012
PubMed

Insights

Interferon regulatory factor 8 (IRF8) drives microglial activation and neuropathic pain following nerve injury. IRF8 deficiency protects against pain, revealing a key mechanism in neuroinflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia, the immune cells of the central nervous system, become activated in response to neural damage and contribute to neuronal pathologies.
  • The precise molecular mechanisms governing the transformation of microglia into reactive phenotypes remain incompletely understood.

Purpose of the Study:

  • To identify key regulators involved in microglial activation and the development of neuropathic pain.
  • To elucidate the role of transcription factors in mediating microglial responses to peripheral nerve injury (PNI).

Main Methods:

  • Investigated the expression of transcription factor interferon regulatory factor 8 (IRF8) in microglia following PNI in a mouse model.
  • Utilized in vitro cultured microglia to assess the functional impact of IRF8 overexpression on gene transcription.
  • Assessed neuropathic pain behaviors in IRF8-deficient mice and evaluated the effects of microglia transplantation.

Main Results:

  • IRF8 expression was significantly upregulated in spinal cord microglia after PNI, but not in neurons or astrocytes.
  • IRF8 overexpression in microglia promoted the transcription of reactive genes, while IRF8 deficiency prevented these changes post-PNI.
  • IRF8-deficient mice exhibited resistance to neuropathic pain, and transfer of IRF8-overexpressing microglia induced pain.

Conclusions:

  • Interferon regulatory factor 8 (IRF8) acts as a critical regulator of microglial activation and the development of neuropathic pain.
  • IRF8 appears to initiate a gene expression program that converts microglia into a reactive phenotype following nerve injury.
  • These findings uncover a novel molecular mechanism underlying microglial activation in the context of neuronal damage and pain.